In its latest budget request, the administration aims to slash 38 percent, or $2.9 billion, from the U.S. President’s ...

This month, lenacapavir is expected to receive FDA approval for pre-exposure prophylaxis (PrEP). It could very well be that ...

The Trump administration's plan to cut funding for HIV vaccine research comes at a time when the field is making substantial ...

Learning the best type of HIV prevention for those at highest risk can start with conversations about their options, writes ...

Gilead Sciences Inc. (NASDAQ:GILD) is one of the 12 best healthcare stocks to buy now. Nevertheless, the company suffered a ...

AI can help public health agencies in the quest to end HIV. The United States is pursuing an initiative to end the HIV ...

On May 30, a team of researchers funded by the National Institutes of Health got the word: Funding for their vaccine ...

Analysis reveals initiating anal cancer screening at age 35 years or older among men who have sex with men (MSM) with HIV is ...

Research keeps you on the forefront and provides opportunities for patients and staff. It’s the only way we’ll ever move ...

Dr. Cathy Creticos with the Howard Brown Health Center has been at the forefront of HIV and AIDS research and treatment for ...

Posttraumatic stress disorder in veterans with HIV increases the risk for AIDS and multiple chronic conditions, especially in ...